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Abstract.  P-selectin (CD62,  GMP-140, PADGEM), a 
Ca2+-dependent  lectin on activated platelets and endo- 
thelium,  functions as a  receptor for myeloid cells by 
interacting  with sialylated, fucosylated lactosaminogly- 
cans.  P-selectin binds to a  limited number of protease- 
sensitive sites on myeloid cells, but the protein(s) that 
carry the glycans recognized by P-selectin are unknown. 
Blotting of neutrophil or HL-60 cell membrane ex- 
tracts with [m25I]P-selectin and affinity chromatography 
of [3H]glucosamine-labeled HL-60 cell extracts were 
used to identify P-selectin ligands.  A  major ligand was 
identified with an =250,000 Mr under nonreducing 
conditions and =120,000 under reducing conditions. 
Binding of P-selectin to the ligand was Ca  2§ dependent 
and was blocked by mAbs to P-selectin.  Brief sialidase 
digestion of the ligand increased its apparent molecu- 
lar weight; however, prolonged digestion abolished 
binding of P-selectin.  Peptide:N-glycosidase F treat- 
ment reduced the apparent molecular weight of the 
ligand by =3,000 but did not affect P-selectin binding. 
Western blot and immunodepletion experiments indi- 
cated that the ligand was not lamp-I,  lamp-2,  or 
L-selectin,  which carry sialyl Le  ~, nor was it leukosia- 
lin,  a heavily sialylated glycoprotein of similar molec- 
ular weight.  The preferential interaction of the ligand 
with P-selectin suggests that it may play a role in 
adhesion of myeloid cells to activated platelets and en- 
dothelial cells. 
T  rI~ selectins  are three structurally related  membrane 
glycoproteins that  participate  in leukocyte adhesion 
to vascular endothelium and platelets (McEver,  1991). 
P-selectin  (CD62), previously known as GMP-140 or PAD- 
GEM protein, is a receptor for neutrophils  and monocytes 
that  is  rapidly translocated from secretory granule  mem- 
branes to the plasma membrane of activated platelets (Ham- 
burger and McEver, 1990; Larsen et al.,. 1989) and endothe- 
lial cells (Geng et al., 1990; Lorant et al., 1991). E-selectin 
(ELAM-1) is a cytokine-inducible endothelial  cell receptor 
for neutrophils  (Bevilacqua  et al.,  1987), monocytes (Hes- 
sion et al., 1990), and memory T cells (Picker et al., 1991a; 
Shimizu  et al.,  1991). L-selectin (LAM-1,  LECAM-1),  a 
protein expressed on myeloid cells and most lymphocytes, 
participates  in neutrophil  extravasation  into inflammatory 
sites and homing of lymphocytes to peripheral lymph nodes 
(Lasky et al.,  1989; Siegelman  et al.,  1989; Kishimoto et 
al.,  1989; Watson et al.,  1991). 
Each selectin functions as a Ca2+-dependent lectin by rec- 
ognition of sialylated glycans. Both E- and P-selectin interact 
with sialylated,  fucosylated lactosaminoglycans  on opposing 
cells,  including  the  sialyl  Le  x tetrasaccharide  (Phillips  et 
al.,  1990; Walz et al.,  1990;  Lowe et al.,  1990; Tiemeyer 
et al., 1991; Goelz et al., 1990; Polley et al., 1991; Zhou et 
al.,  1991). However, the precise carbohydrate structures on 
myeloid cells recognized by these two selectins under physi- 
ologic conditions are not known.  Such ligands  might  have 
unique  structural  features  that  enhance the binding  spec- 
ificity and/or affinity for their respective receptors. 
P-selectin isolated from human platelets binds with appar- 
ent high affinity to a limited number of sites on neutrophils 
(Moore et al.,  1991; Skinner  et al.,  1991) and HL-60 cells 
(Zhou et al., 1991). Binding is abolished by treatment of the 
cells with proteases (Moore et al.,  1991), suggesting  that 
the glycans  on myeloid cells recognized preferentially  by 
P-selectin are on glycoprotein(s)  rather than on glycolipids. 
The number of binding sites for platelet P-selectin on neutro- 
phils has been estimated at 10,000-20,000  per cell (Moore 
et al., 1991; Skinner et al., 1991), suggesting that these sites 
constitute a small component of the total cell surface protein. 
The protein portion of this ligand(s) may be crucial for bind- 
ing  by presenting  the glycan in an optimal  configuration, 
clustering glycans to enhance avidity, favoring the formation 
of specific  oligosaccharide structures by cellular glycosyl- 
transferases  or modifying enzymes, and/or stabilizing  the 
lectin-carbohydrate interaction  through  protein-protein in- 
teractions  with P-selectin. 
The potential  importance of protein components in en- 
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transfected with a specific fucosyltransferase (Zhou et al., 
1991). These cells express higher amounts of the sialyl Le  ~ 
antigen than do HL-60 cells and have protease-sensitive  bind- 
ing sites for P-selectin. However, the interaction of P-selectin 
with these sites is of much lower apparent affinity than with 
those on myeloid cells, and adhesion of transfected CHO 
cells to immobilized P-selectin is weaker than that of neutro- 
phils and HL-60 cells (Zhou et al.,  1991). These observa- 
tions suggest that myeloid cells express one or more mem- 
brane glycoproteins not found on CHO cells that enhance the 
lectin-mediated  interaction with  P-selectin.  Alternatively, 
myeloid cells may express a glycosyltransferase or modify- 
ing enzyme not present in CHO cells. 
In this study we demonstrate that P-selectin binds primar- 
ily to a single major glycoprotein ligand on neutrophils and 
HL-60 cells, when assessed by blotting assays and by affinity 
chromatography  of  [3H]glucosamine-labeled  HL-60  cell 
extracts on immobilized P-selectin. We present preliminary 
characterization of this molecule and demonstrate that it can 
be distinguished from other well-characterized neutrophil 
membrane proteins with similar apparent molecular mass. 
Materials and Methods 
Materials 
Wheat germ agglutinin (WGA)l-agarose, pepstatin, aprofinin, N-acetyl- 
glucosamine, leupeptin, antipain, benzamidine, MOPS, Pipes, BSA, EDTA, 
EGTA, and Ponceau S were purchased from Sigma Chemical Co. (St. Louis, 
MO). Diisopropytfluorophosphate, dichloroisocoumarin,  Triton X-100 (pro- 
tein grade), and sialidase (neuraminidase) from Arthrobacter ureafaciens 
(75 U/mg, EC 3.2.1.18) were obtained from Calbiochem-Behring  Corp. (La 
Jolla, CA).  Micro BCA protein assay kits and Lubrol PX (Surfact Amp 
PX) were purchased from Pierce Chemical Company (Rockford,  IL). En- 
zymobeads  TM, Tween-20,  Affigel-15, and high molecular weight protein 
standards were from Bio-Rad Laboratories  (Richmond,  CA). Endo-fl-galac- 
tosidase (150 U/mg, EC 3.2.1.103) from Bacteroidesfragilis,  4-methyl-um- 
bellifeD.l-ot-N-acetylneuraminic  acid, and 2,3-dehydro-2,3-dideoxy-N-ace- 
tylneuraminic acid (Neu2en5Ac) were obtained from Boehringer Mannheim 
Biochemicals (Indianapolis,  IN). Peptide:N-glycosidase  F (PNGaseF) from 
Flavobacterium meningosepticum (EC 3.2.2.18,  N-glyeanase) and endo-a- 
N-acetylgalactosaminidase  from Diplococcus  pneumoniae  (EC  3.2.1.97, 
O-glycanase TM) were purchased from Genzyme (Cambridge,  MA). HBSS 
was obtained from Gibco Laboratories (Grand Island, NY).  VectaStain 
ABC kits were purchased from Vector Laboratories Inc. (Burlingame, CA). 
Phycoerythrin-streptavidin was obtained from Becton Dickinson &  Co. 
(San Jose,  CA) and phycoerythrin-conjugated  anti-mouse IgGl was from 
Caltag (South San Francisco,  CA). Rabbit anti-mouse IgG was purchased 
from Organon Teknika (Durham, NC) and protein A-Sepharose CL4B was 
from Pharmacia Fine Chemicals (Piscataway, NJ). [6-3H]glucosamine  was 
obtained from Dupont/New England Nuclear (Boston,  MA).  All other 
chemicals were of the highest grade available. 
Antibodies and Proteins 
The anti-P-selectin  murine mAbs S12 and G1, and goat anti-human P-selee- 
tin IgG were prepared and characterized as previously described (McEver 
and Martin, 1984; Geng et al., 1990; Lorant et al., 1991). Rabbit polyclonal 
antisera and murine mAbs to human lamp-1 (CD3) (Carlsson et al., 1988) 
and lamp-2  (BB6)  (Carlsson and Fukuda,  1989),  and rabbit polyclonal 
anti-human leukosialin antiserum (Carlsson and Fukuda, 1986) were pro- 
vided by Dr. Sven Cadsson (University of Umefi, Umefi, Sweden).  Anti- 
human leukosialin (CD43)  mAb (Leu-22)  was  purchased from Becton 
Dickinson & Co. (San Jose, CA). The anti-L-selectin murine mAb antibod- 
1. Abbreviations used in this paper: Lamp, lysosomal-associated  membrane 
protein;  Neu2en5Ac,  2,3-dehydm-2,3-dideoxy-N-acetylneuraminic  acid; 
PNGaseF,  Peptide:N-glycosidase  F; WGA, wheat germ agglutinin. 
ies DREG-56,  DREG-55,  and DREG-200 (Kishimoto et al.,  1990) were 
provided by Dr. Takashi Kei Kishimoto (Boehringer Ingelheim Pharmaceu- 
ticals,  Inc., Ridgefield,  CT). All mAbs are of the IgGl subtype and were 
used in purified form. Leukosialin purified from HL-60 cells (Carlsson and 
Fukuda,  1986) was provided by Dr. Sven Carlsson (University of Umefi). 
P-selectin  was  purified  from  human ptatelets  as  previously  described 
(Moore et al.,  t99D. 
Preparation of  Membranes 
Erythrocyte  membranes  were  isolated  from  leukocyte-depleted  human 
erythrocytes as previously described (Rollins and Sims, 1990) and extracted 
with 0.1  M  NaCl,  10 mM MOPS,  pH 7.5, 1%  Lubrot PX.  Detergent- 
insoluble material was removed by centrifugation at 16,000 g for  10 min. 
Human neutrophils isolated by discontinuous leukopheresis  from volun- 
teer donors were purchased from the Oklahoma Blood Institute (Oklahoma 
City, OK). Each product comained 1.5-3.3  ￿  l0 t~ leukocytes (=85% neu- 
trophils).  The neutrophil  product was centrifuged at 200 g for 20 rain and 
the platelet-rich plasma removed. Erythrocytes were lysed by resuspending 
the pellets with 5 mM EDTA, pH 7.5, in H20 for 20 s. An equal volume 
of 1.8% NaC1, 5 mM EDTA, pH 7.5, was then added to restore isotonicity. 
The cells were centrifuged  at 500 g for 5 min and resuspended  in ice-cold 
HBSS  containing  5  mM  EDTA  and  10  mM  MOPS,  pH  7.5. Di- 
isopropylfluorophosphate  was then added to a final concentration of 2 mM 
and the cell suspension incubated for 10 min on ice. The ceils were cen- 
trifuged  at 500 g for 5 min at 4~  and resuspended  in ice-cold  100 mM 
KC1, 3 mM NaCl,  1 mM Na2ATP, 3.5 mM MgC12, 10 mM Pipes, pH 7.3 
(relaxation  buffer).  To this suspension the following  protease inhibitors 
were added at the indicated  final concentrations: 2 mM diisopropylfluoro- 
phosphate, 20 ~M leupeptin,  30 tzM anfipain, and 1 mM benzamidine. The 
cell suspension was pressurized with N2 at 350 psi in a cell disruption 
bomb (model 4635; Parr Instrument Company,  Moline, IL) for 40 min at 
4~  with constant stirring as  described previously  (Borregaard  et al., 
1983). The cavitate was collected into EGTA (2 mM final concentration) 
and nuclei and undisrupted cells were pelleted at 500 g for 10 min at 4~ 
The cavitate was fractionated as previously  described (Eldund and Gabig, 
1990). Briefly, it was layered over 40% sucrose in relaxation buffer contain- 
ing 2 mM EGTA, 20 t~M leupeptin, 30 #M antipain, and 1 mM benzami- 
dine, and centrifuged at 104,000  g  (at ray) for 45 min at 4~  in a rotor 
(model SW28; Beckman Instruments, Inc., Palo Alto, CA). The top layer 
(FXt), the 40% sucrose layer (FX2), and the granule pellet (FX3) were col- 
lected and assayed for lactate dehydrogenase as a cytoplasmic marker, alka- 
line phosphatase as a plasma membrane marker,  and myeloperoxidase  as 
a marker for azurophilic granules as previously  described (Borregaard  et 
ai., 1983; Geng et al., 1990). Table I shows the distribution of marker en- 
zymes in the various fractions.  FX2,  enriched for alkaline phosphatase, 
was diluted with four volumes of 0.1 M NaCl, 10 mM MOPS, pH 7.5, and 
centrifuged  at 111,000 g (at ray) for 60 min at 4~  in a rotor (model 50.2 
Ti;  Beckman Instruments, Inc.).  The supernatant was collected  and the 
membrane pellet was extracted  with 1% Lubrol PX, 0.1 M NaCl,  10 mM 
MOPS,  pH 7.5, 0.02%  sodium  azide,  20/xM leupeptin,  30 ~M antipain, 
1 mM benzamidine, and stored at 4~ 
HL-60  cells,  maintained in  suspension culture  in  RPMI-1640  sup- 
plemented with 10% FCS,  100 IU/ml penicillin, and 100/~g/ml streptomy- 
cin were washed in HBSS,  10 mM MOPS,  pH 7.5, and membranes were 
isolated  exactly as described for neutrophils. 
Partial Purification of P-selectin Ligand 
Neutrophil or  HL-60  cell membrane extracts  were  applied  to a  WGA 
affinity column (0,9  x  20 cm, 7.6 mg lectin/ml resin) equilibrated at room 
temperature with 0.5 M NaCI,  10 mM MOPS, pH Z5, 0.02 % sodium azide, 
0.1% Lubml PX.  The column was washed  with five column volumes  of 
equilibration buffer, followed by two column volumes of 0.1 M NaCI,  10 
mM MOPS, pH 7.5, 5 mM EDTA, 0.02% sodium azide, 0.01% Lubrol PX. 
The column was  then eluted with the above buffer containing 100 mM 
N-acetylglucosamine.  Protein-containing fractions were pooled and exten- 
sively dialyzed against (3.1 M NaC1, 10 mM MOPS, pH 7.5, 0.02% sodium 
azide, 0.01% Lubrol PX at 4~  The dialyzed WGA column eluate was made 
1 mM in CaCI2 and MgC12 and applied to a human serum albumin Affigel- 
15 precolumn (0.9  x  11 cm, 25 mg protein/ml resin) hooked in series to 
a P-selectin-Aftigel  15 column (0.6 ￿  13 cm, 2 mg protein/ml resin). The 
columns were equilibrated with 0.I M NaC1, 10 mM MOPS, pH 7.5, 1 mM 
CaCI2,  1 mM MgCI2, 0.02%  sodium azide,  0.01% Lubrol PX. After the 
samples were applied the columns were washed with 100 column volumes 
of equilibration buffer,  and elnted with equilibration buffer containing 5 
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Fractions of  Nitrogen-cavitated Human Neutrophils 
Lactate  Alkaline 
dehydrogenase  Myeloperoxidase  phosphatase 
FX~  (cytosol)  95.6  +  0.5  0  29.0  +  2.7 
FX_~ (membrane)  4.1  +  0.5  2.6  +  1.0  56.8  +  8.7 
FX3  (granule)  0  97.4  _  1.0  14.1  +  5.5 
Results are expressed as the percentage of the total enzyme activity in the cavi- 
tate  (mean _+  SD, n  =  3). 
mM EDTA. Yields were estimated by protein assays with the Micro BCA 
protein assay kit using BSA as a  standard. 
P-selectin Blotting Assay 
Samples were electrophoresed on 7.5 % SDS-polyacrylamide gels and pro- 
teins electrophoretically transferred to Immobilon-P membranes (Millipore 
Corp., Bedford,  MA) for 4-5 h at 0.5 A.  The positions of the molecular 
weight standards were marked with a pen after staining the membranes with 
Ponceau S. The membranes were blocked overnight at 4~  in 0.1 M NaCI, 
10 mM MOPS, pH 7.5,  1 mM CaCI2, 1 mM MgCl2, 0.02% sodium azide, 
10% (wt/vol) Carnation  TM nonfat dry milk, and then washed with the same 
buffer containing 0.1%  Tween-20 without milk. The membranes were in- 
cubated  with  [1251]P-selectin  (0.5-1.0  nM),  iodinated  as  previously de- 
scribed (Moore et al.,  1991), in 0.1 M NaCI, 10 mM MOPS, pH 7.5,  1 mM 
CaC12,  1 mM MgCI2, 0.05% Lubrol PX, 1% human serum albumin for 1 h 
at room temperature. After extensive washing the membrane was dried and 
exposed to Kodak X-OMAT AR film (Eastman Kodak Company, Rochester, 
NY) for 6-18 h at  -70~  All the [125I]P-selectin  blots shown are autora- 
diograms of the entire blot, corresponding to the area from the stacking gel 
interface to beyond the dye front on the original gel. 
Metabolic Radiolabeling of  ilL-60 Cells and Isolation 
of  l~H]glucosamine-labeled P-selectin Ligand 
HL-60 cells (1-2  x  l06 cells/ml) in 100-ram tissue culture dishes were la- 
beled for 48 h with 50/~Ci/ml [6-3H]glucosamine at 37~  in RPMI-1640 
containing  10%  FCS,  2  mM glutamine,  100 IU/ml penicillin,  and  100 
#g/ml streptomycin. At the end of the labeling period the cells were washed 
three times by centrifugation and resuspension in ice-cold PBS.  The cell 
pellet was solubilized with 0.1  M  NaCl,  10 mM MOPS,  pH 7.5,  4  mM 
CaC12,  4  mM MgCl2,  1%  Triton  X-100,  20  /~g/ml  aprotinin,  20 /~g/ml 
leupeptin,  8  /~g/ml  pepstatin,  2  mM PMSE  10  mM benzamidine,  and 
0.5 mM dichloroisocoumarin. The solubilized cells were allowed to sit on 
ice for 1-2 h and then sonicated for 20 min at 4~  in a water bath sonicator. 
The cell extract was centrifuged for 5 min at 16,000 g and the supernatant 
was applied to a  P-selectin-Afiigel-15 column (0.25  x  13 cm, 2  mg pro- 
tein/ml resin) equilibrated with 0.1 M NaCl, l0 mM MOPS, pH 7.5, 2 mM 
CaCl2, 2  mM MgCl2, 0.1%  Triton X-100.  The column was washed with 
10-20  column volumes of equilibration  buffer and bound material  was 
eluted with equilibration buffer containing 10 mM EDTA. Fractions (1 ml) 
were  collected  and  monitored  for  radioactivity  by  liquid  scintillation 
counting. 
Analysis of  pH]glucosamine-labeled P-selectin Ligand 
Metabolically  labeled  proteins eluted  from  the  P-selectin column were 
precipitated in the presence of 0.1 mg/ml BSA by addition of cold TCA (10% 
final concentration). The resulting pellets were washed with 1 ml acidified 
acetone (0.2%),  solubilized in 0.1  M  NaOH and electrophoresed under 
reducing and nonreducing conditions on  10%  SDS-polyacrylamide gels. 
The gels were stained with Coomassie blue and then processed for fluorog- 
raphy with EN3HANCE (Dupont/New England Nuclear, Boston, MA) ac- 
cording to the manufacturer's instructions. The dried gels were then ex- 
posed to Kodak X-OMAT AR film at  -80~ 
Enzyme Digestion 
In  certain  experiments,  samples  analyzed  by  P-selectin  blotting  were 
pretreated with exo- or endo-glycosidases before SDS-PAGE. For sialidase 
and endo-13-galactosidase digestions of P-selectin ligand, samples were dia- 
lyzed against 0.15  M  NaCI, 50 mM acetate, pH 6.0, 9 mM CaCI2, 0.02% 
azide,  0.01%  Lubrol PX, and incubated for various times at 37~  in the 
presence or absence of 200 mU/ml of enzyme. For PNGaseF and endo- 
a-N-acetylgalactosaminidase digestions,  samples were  first reduced  and 
denatured by boiling in 0.5 % SDS, 0.5 % fl-mercaptoethanol for 5 min, and 
then a  7.5-fold molar excess of NP-40 was added.  The samples were in- 
cubated for 16 h at 37~  with either PNGaseF (20 U/ml at pH 8.6) or endo- 
ot-N-acetylgalactosaminidase  (70 mU/ml at pH 6.5) in the presence of 5 mM 
PMSF and 5  mM 1,10-phenanthroline. 
Affinity-purified  [3H]glucosamine-labeled  P-selectin  ligand  was  in- 
cubated for 24 h in 25 mM sodium acetate, pH 5.5 at 37~  under a toluene 
atmosphere in the presence or absence of 1 U/ml ofA. ureafaciens sialidase 
for 18 h. For PNGaseF digestion of metabolically labeled ligand, samples 
were denatured by boiling in 0.25%  SDS, 25 mM/3-mercaptoethanol for 
5  min, and NP-40 was added in eight-fold excess (wt/wt) over SDS.  The 
samples were incubated for 24 h with PNGaseF (3.3 U/ml) in a toluene at- 
mosphere. The samples were then precipitated with TCA and subjected to 
SDS-PAGE and fluorography as described above. 
Flow Cytometry 
Human  neutrophils,  isolated  as  previously  described  (Hamburger  and 
McEver,  1990), were suspended (106/ml)  in HBSS containing 1% FCS and 
0.1% sodium azide (HBSS/FCS/Az).  1 ml of neutrophil suspension was un- 
derlaid with 100 #1 FCS and centrifuged at 500 g for 5 min. The neutrophil 
pellet was resuspended in 50 ~1 of purified P-selectin (10/zg/ml, in HBSS/ 
FCS/Az), and then incubated sequentially with 50/~l of biotin-conjugated 
S12 (10 #g/ml, in HBSS/FCS/Az) and 20 #l of phycoerythrin-streptavidin 
(neat). In certain experiments, the neutrophils were preincubated for 10-15 
min with antisera or antibodies before the addition of P-selectin. Between 
each step the cells were diluted with one ml of HBSS/FCS/Az,  underlaid 
with 100 ~ul FCS, and centrifuged at 500 g  for 5 min. All steps were per- 
formed at 4~  After the last wash, the cells were fixed with  1 ml of 1% 
paraformaldehyde in  HBSS  and analyzed in a  FACScan flow cytometer 
(FACScan is a registered trademark of Becton Dickinson & Co., Mountain 
View, CA) formatted for two-color analysis as previously described (Moore 
et al.,  1991).  Binding of P-selectin to intact neutrophils as assessed by this 
assay was Ca2+-dependent, was blocked by G1, and was abolished by pre- 
treatment of the cells with trypsin or sialidase (data not shown). 
lmmunoprecipitations 
WGA eluate was incubated with 10 #g of anti-leukosialin (Leu22) or an iso- 
type matched control monoclonal antibody for  1 h at 37~  The mixture 
was then incubated with protein A-Sepharose CIAB beads saturated with 
rabbit anti-mouse IgG for  1 h at 37~  The beads were pelleted,  washed 
four times with 1 ml of 0.1 M NaCl, 20 mM Tris, pH 7.5,  1% Triton X-100, 
and bound material eluted by boiling 5 rain in 2%  SDS, 60 mM Tris, pH 
6.8, and 5 %/3-mercaptoethanol. Immunoprecipitates and immunosuperna- 
tants were then analyzed by P-selectin blotting and by Western blotting using 
Leu22 as a  probe. 
Assay of Sialidase Activity in Commercial 
Enzyme Preparations 
The sialidase activity in O-glycanase (endo-a-N-acetylgalactosaminidase) 
or A. ureafaciens sialidase was assayed by incubation of dilutions of the en- 
zymes with 50 nmol 4-methyl-umbelliferyl-t~-N-acetylneuraminic acid in 
50 #l of sodium cacodylate, pH 6.5,  10 mM calcium acetate,  for various 
time periods. Incubations were quenched by addition of 0.95 ml 0.1 M  so- 
dium bicarbonate, pH 9.3, and assayed for released 4-methylumbelliferone 
by fluorescence (excitation  =  365 nM, emission =  450 nM). 
Results 
Identification of a P-selectin Ligand 
To identify proteins from myeloid cells which bind P-selec- 
tin, neutrophil and HL-60 cell membrane extracts were elec- 
trophoresed on 7.5 % SDS-polyacrylamide gels, transferred 
to Immobilon membranes, and probed with [~25I]P-selectin. 
When samples were analyzed without reduction,  P-selec- 
tin bound preferentially to a  glycoprotein species with an 
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and erythrocyte (RBC) membrane extracts. Cell membrane extracts 
(80/zg protein/lane) were electrophoresed on 7,5 % SDS-polyacryl- 
amide gets under nonreducing or reducing conditions, transferred 
to lmmobilon membranes, and probed with [~2~I]P-selectin  as de- 
scribed in Materials and Methods. DF, dye front. 
=250,000 Mr  from both neutrophil and  HL-60 cell mem- 
branes  (Fig.  1).  Under nonreducing conditions P-selectin 
also bound to proteins at the stacking gel interface and to a 
minor species with an =160,000 Mr.  When samples were 
analyzed after reduction, P-selectin preferentially bound to 
a glycoprotein with an =120,000 Mr (Fig.  1). Minor bands 
were observed at =250,000 and =90,000. Under both reduc- 
ing and nonreducing conditions P-selectin also bound to the 
blots at the dye front (Figs. 2  and 3 a).  P-selectin binding 
proteins were not detected when an equivalent amount of 
erythrocyte  membrane protein was analyzed in parallel (Fig. 
1). We also directly solubilized the total proteins in the neu- 
trophil cavitate with SDS and analyzed their ability to inter- 
act with P-selectin with the blotting assay.  P-selectin bound 
only to proteins with apparent molecular weights of 120,000 
and 90,000 under reducing conditions (data not shown). Al- 
though  the  sensitivity of this  analysis  was  limited by the 
amount of protein that could be run on the gel, the results 
indicate that we did not exclude major ligands that were ei- 
ther not enriched in  the membrane fraction (FX2)  or not 
effectively solubilized by nonionic detergent. 
To further assess the specificity of the blotting assay, neu- 
trophil membrane extracts electrophoresed under reducing 
conditions were probed with [~25I]P-selectin in the presence 
or absence of EDTA or anti-P-selectin mAbs. Fig. 2 shows 
that  [~5I]P-selectin binding  to the major  120-kD and the 
minor 259-kD species was Ca2§  a characteristic 
of  all  selectin-dependent  cellular  interactions  (McEver, 
1991).  Binding to both species was also blocked by G1, a 
mAb to P-selectin that inhibits adhesion of myeloid cells to 
P-selectin, but not by S12, a mAb to P-selectin that does not 
Figure 2. Effect of EDTA or anti-P-selectin antibodies on [125I]P- 
selectin binding to the neutrophil ligand. Neutrophil membrane 
extracts (200/~g protein/lane) were electrophoresed on 7,5 % SDS- 
polyacrylamide gels under reducing conditions, transferred to Im- 
mobilon membranes, and probed with [125I]P-selectin  alone, in the 
presence of 10 mM EDTA, or in the presence of 20/~g/ml of the 
anti-P-selectin mAbs G1 or S12. 
block  adhesion.  Binding  of  [~:5I]P-selectin  was  also  in- 
hibited by a 100-fold excess of unlabeled P-selectin (data not 
shown). The binding of [~25I]P-selectin to the dye front and 
to the 90-kD protein was not blocked by EDTA or G1, sug- 
gesting that these interactions were nonspecific or used a 
specific Ca2§  recognition mechanism. 
Partial Purification  of  P-selectin Ligand 
from Neutrophils 
Neutrophils  were  disrupted  and  the  membrane  fraction 
(FX2) isolated by fractionation of the cavitate as described 
in Materials and Methods. The membrane fraction consti- 
tuted =5-7% (n >10) of the protein in the cavitate. This frac- 
tionation depleted both cytosolic proteins and azurophilic 
granules (Table I). Proteins binding P-selectin were not de- 
tected in the cytosolic fraction (FX0 with the blotting as- 
say. The final membrane pellet was solubilized with nonionic 
detergent and applied to a WGA column which bound 4-5 % 
of  the protein in the membrane extract. P-selectin blotting as- 
says of reduced proteins demonstrated that both the major 
120-kD and the minor 250-kD ligands bound quantitatively 
to WGA. However, the 90-kD band and the band at the dye 
front observed in the membrane extract were not bound by 
WGA (Fig. 3 a). After extensive dialysis, the WGA eluate was 
applied to an Affigel-15 precolumn in series with a P-selec- 
The Journal of Cell Biology, Volume 118,  1992  448 Figure  3. Partial  purification  of  the P-selec- 
tin ligand from neutrophils by sequential 
WGA and P-selectin affinity chromatog- 
raphy. (A)  Samples from the  indicated 
steps of  the isolation procedure were elec- 
trophoresed  on  7.5% SDS-polyacryl- 
amide  gels under  reducing conditions, 
transferred  to  Immobilon  membranes, 
and  probed with  [12sI]P-selectin. The 
amounts of protein loaded onto the lanes 
were as follows: membrane extract and 
WGA flow through, 200 pg; WGA eluate 
and P-selectin flow through, 50/zg; P-se- 
lectin eluate, 2/~g. (B) The same samples 
(10 #g protein/lane) were also analyzed 
by SDS-PAGE under reducing conditions 
followed by silver staining. 
tin  affinity column.  Approximately 2%  of the protein  in 
the WGA eluate bound to the P-selectin column and could 
be eluted with EDTA.  Both the 250-  and the  120-kD  li- 
gands bound quantitatively to the P-selectin column (Fig. 
3  a).  Quantitative analysis of the protein recovered from 
the P-selectin eluate indicated that the ligand(s) comprised 
<0.01% of  the total protein in the neutrophil cavitate. Elution 
of bound proteins from the P-selectin column with EDTA 
demonstrated that the interaction of  nondenatured neutrophil 
ligands with P-selectin was also Ca  2+ dependent.  Neither 
species  was  eluted  from  the  Affigel-15  precolumn  with 
EDTA  (data not shown). 
Fig. 3 b shows a silver-stained SDS-polyacrylamide gel of 
proteins from the various stages in the partial purification 
procedure run under reducing conditions. The major silver- 
stained band in the P-selectin eluate had an =150,000 Mr 
which is  similar to that of P-selectin itself. To determine 
whether this protein represented P-selectin that had leeched 
off the P-selectin column, we analyzed the P-selectin eluate 
by SDS-PAGE under both reducing and nonreducing condi- 
tions, followed by silver staining, Western blotting with goat 
anti-P-selectin IgG, and P-selectin blotting. The major silver- 
stained protein in the P-selectin eluate was indeed P-selec- 
tin. Purified P-selectin migrates with an --120,000 Mr under 
nonreducing conditions; a minor component migrates with 
an =250,000 Mr (McEver and Martin,  1984).  After reduc- 
tion the protein migrates more slowly with an =150,000 Mr 
(McEver and Martin,  1984).  The two nonreduced bands 
and the one reduced band detected by silver staining of the 
P-selectin eluate (Fig. 4 b) co-migrated with purified P-selec- 
tin and were  recognized by anti-P-selectin IgG  (data  not 
shown). The P-selectin ligand identified in the blotting assay 
(Fig. 4 a) was not detected by silver staining and migrated 
differently than P-selectin under both reducing and nonre- 
ducing conditions. When the P-selectin eluate was electro- 
phoresed without reduction, P-selectin did not bind to pro- 
teins at the stacking gel interface (Fig. 4 a). Therefore, the 
P-selectin-binding proteins at the stacking gel interface, ob- 
served in extracts of neutrophil membranes (Fig.  I), were 
probably an artifact due to the relatively high amount of  pro- 
tein loaded on the gel. 
Characterization of the P-selectin Ligand 
The ligand(s) on intact target cells requires sialic acids to in- 
teract with P-selectin (Zhou et al., 1991; Corral et al., 1990; 
Policy et al., 1991; Moore et al., 1991). To determine whether 
the ligand detected by blotting of  neutrophil membranes con- 
tained  sialic acids  that were  essential  for recognition by 
P-selectin, neutrophil membrane glycoproteins which bound 
to WGA were treated with sialidase (200 mU/ml) for varying 
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P-selectin eluate  (2  ~tg protein/lane)  was 
electrophoresed  under  reducing  (R)  and 
nonreducing (NR) conditions,  transferred 
to Immobilon membranes, and probed with 
[~2sI]P-selectin. (B) Eluate from the P-selec- 
tin column (10 #g protein/lane) was electro- 
phoresed on 7.5 % SDS-polyacrylamide gels 
under reducing (R) and nonreducing (NR) 
conditions and stained with silver. 
times before SDS-PAGE under reducing conditions and then 
analyzed for their ability to bind P-selectin (Fig. 5 a). Siali- 
dase digestion for 30 min increased the apparent molecular 
weight of the major  120-kD  ligand,  a  shift characteristic 
of heavily sialylated glycoproteins (Carlsson and Fukuda, 
1986; Segrest et al.,  1971; Cummings et al.,  1983). Longer 
sialidase digestion did not further alter the electrophoretic 
mobility of the  ligand  but did  abolish  its  ability  to  bind 
['25I]P-selectin.  Sialidase treatment had a  similar effect on 
the minor 250-kD ligand. These results demonstrate that the 
ligand(s) contains sialic acid residues that are critical for rec- 
ognition by P-selectin, but suggest that only a portion of the 
sialic acid residues are required for binding. 
To examine whether the ligand contained N-linked glycans, 
neutrophil membrane glycoproteins which bound to WGA 
were digested with PNGaseE This treatment did not affect 
['25I]P-selectin binding but did decrease the apparent molec- 
ular  weight  of the  ligand,  consistent  with  the  enzymatic 
removal of  one or two N-linked glycan chains (Fig. 5 b). This 
demonstrates that the ligand contains at least one N-linked 
oligosaccharide chain that is not required for P-selectin bind- 
ing.  Although we cannot directly assess whether N-linked 
glycans were quantitatively removed from the ligand, we did 
use conditions that normally cleave such glycans from most 
proteins. 
Prolonged treatment of neutrophil membrane extracts with 
endo-ct-N-acetylgalactosaminidase (O-glycanase) abolished 
binding  of  ['2~I]P-selectin  in  the  blotting  assay,  whereas 
sham digestion was without effect (data not shown). This was 
a surprising result, since only nonsialylated Gal/31-3GalNAc 
disaccharides O-linked to serine or threonine residues are 
known substrates for the enzyme (Umemoto et al.,  1977). 
We therefore considered the possibility that the commercial 
enzyme was contaminated with a sialidase.  Assays using a 
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or PNGaseF on the P-selectin 
ligand. Neutrophil WGA elu- 
ate (50 ~g) was either sham- 
treated or digested with 200 
mU/ml of sialidase for the in- 
dicated times (A) or with 20 
U/ml  of PNGaseF  for  16  h 
(B), then electrophoresed on 
7.5 %  SDS-polyacrylamide 
gels  under  reducing  condi- 
tions, transferred to Immobi- 
Ion membranes,  and  probed 
with [~25I]P-selectin. 
synthetic  sialidase  substrate  confirmed the  presence of a 
small amount of sialidase (0.01 mU/mU O-glycanase). Al- 
though  the  level  of activity  was  small,  it  was  stable  to 
prolonged incubations under the conditions recommended 
by the manufacturer for use of the O-glycanase preparation. 
To prove that the contaminating  sialidase was  responsible 
for the loss of P-selectin binding,  the digestions were re- 
peated in the presence of a competitive sialidase inhibitor, 
Neu2en5Ac. Under these conditions endo-ct-N-acetylgalac- 
tosaminidase digestion had no effect on [lzsI]P-selectin bind- 
ing to the ligand or the apparent molecular weight of the 
ligand (data not shown). Because the ligand requires sialic 
acid to interact with P-selectin, we could not use the blotting 
assay to assess the role of O-linked glycans in recognition by 
P-selectin. 
Isolation of  a P-selectin Ligand  from Metabolically 
Labeled HL-60 Cells 
P-selectin blotting  of denatured  membrane proteins  from 
myeloid cells may not detect molecules whose ability to bind 
P-selectin is dependent on secondary and/or tertiary struc- 
ture.  As  an  independent approach to  identify ligands  for 
P-selectin,  HL-60  cells  were  metabolically  labeled  with 
[3H]glucosamine, solubilized with nonionic detergent, and 
applied to a P-selectin affinity column. After extensive wash- 
ing, bound material was eluted with EDTA and analyzed by 
SDS-PAGE followed by fluorography. Fig. 6 a  shows  that a 
single metabolically labeled species was eluted, which co- 
migrated under both nonreducing and reducing conditions 
with the major species detected in neutrophil and HL-60 cell 
membranes by blotting with [~25I]P-selectin. Only 0.15-0.5 % 
of the total  [3H]glucosamine-labeled HL-60 glycoproteins 
bound to the P-selectin column, indicating that the ligand is 
not abundant.  Sialidase treatment of the [3H]glucosamine- 
labeled  P-selectin ligand  from HL-60 cells produced the 
same  increase in  apparent molecular weight that was  ob- 
served  for  the  major  neutrophil  ligand  identified  by  the 
P-selectin blotting assay (Fig.  6  b).  In addition,  PNGaseF 
treatment caused the same decrease in the apparent molecu- 
lar weight of the HL-60 cell ligand that was observed for the 
neutrophil ligand (Fig.  6 c). 
Comparison of the P-selectin Ligand with Known 
Neutrophil Membrane Proteins 
We compared the properties of the major 120-kD P-selectin 
ligand with those of three well-characterized neutrophil mem- 
brane proteins with similar apparent molecular weight. The 
first two molecules, lamp-1 and lamp-2, are abundant neutro- 
phil proteins that are predominantly localized in lysosomal 
membranes but are also expressed in small amounts on the 
cell surface. These proteins have a large number of complex 
N-linked glycan chains (Fukuda et al., 1988; Carlsson et al., 
1988; Carlsson and Fukuda, 1990), many of which carry the 
sialyl Le  x tetrasaccharide (Lee et al.,  1990). Polyclonal an- 
tisera (1:5 dilution) and mAbs (40/zg/ml) to lamp-1  (CD3) 
and lamp-2 (BB6) had no effect on binding of P-selectin to 
neutrophils as assessed by flow cytometry (data not shown). 
Western blot analysis of neutrophil membranes with mAbs 
to lamp-1 and lamp-2 showed that the electrophoretic mobili- 
ties of these proteins under nonreducing conditions were dis- 
tinct from that of the P-selectin ligand (Fig. 7 and Carlsson 
et al., 1988). In contrast to the P-selectin ligand, the electro- 
phoretic mobilities of lamp-1 and lamp-2 are not affected by 
sialidase treatment (Carlsson et al., 1988). Although lamp-1 
and lamp-2 from myeloid cells are rich in lactosaminoglycans 
sensitive  to  endo-/3-galactosidase  (Carlsson  et  al.,  1988; 
Carlsson and Fukuda, 1990), treatment of intact neutrophils 
with  the  enzyme did  not  affect binding  of [~25I]P-selectin 
(Moore et al., 1991). Pretreatment of crude neutrophil mem- 
brane extracts or WGA column eluate with endo-/3-galac- 
tosidase (200 mU/ml,  1-2 h,  37~  also did not affect the 
apparent  molecular  weight  of the  ligand  or  its  ability  to 
Moore et al. P-Selectin Ligand  451 Figure 6. Analysis of the P-selectin ligand purified from [3H]glucosamine-labeled  HL-60 cells by P-setectin affinity chromatography. (A) 
Samples were electrophoresed on 10% SDS-polyacrylamide gels under both nonreducing (NR) and reducing (R) conditions and analyzed 
by fluorography. Other samples were either sham treated or digested with 1 U/ml of sialidase for 24 h (B) or with 3.3 U/ml of PNGaseF 
for 24 h (C), and then electrophoresed on 10% SDS-polyacrylamide gels under reducing conditions and analyzed by fluorography. 
bind [~25I]P-selectin (data not shown). These data argue that 
lamp-1 and lamp-2 are not ligands for P-selectin even though 
they carry many sialyl Le  x structures. 
The third molecule whose apparent molecular weight is 
similar to the 120-kD P-selectin ligand is CD43 (leukosialin, 
sialophorin), a heavily sialylated membrane protein present 
on platelets and  all leukocytes (Remold-O'Donnell et al., 
1986; Carlsson and Fukuda, 1986; Pallant et al., 1989; Shel- 
ley et al.,  1989). It carries numerous O-linked sugar chains 
and is differentially glycosylated by cells of various hemato- 
poietic lineages (Carlsson et al.,  1986). Like the P-selectin 
ligand, treatment of leukosialin with sialidase increases its 
apparent molecular weight (Carlsson and  Fukuda,  1986). 
However,  in  contrast  to  the  P-selectin  ligand,  the  elec- 
trophoretic mobility of leukosialin was unaffected by reduc- 
tion (Fig.  7;  Carlsson and Fukuda,  1986;  Carlsson et al., 
1988). Monospecific polyclonal anti-human leukosialin an- 
tisera (1:5 dilution) did not inhibit P-selectin binding to neu- 
trophils as  assessed  by flow cytometry (data  not  shown). 
Furthermore, immunodepletion of leukosialin from neutro- 
phil membrane extracts did not deplete P-selectin ligand as 
assessed by the blotting assay (data not shown). Finally, leu- 
kosialin purified from HL-60 cells did not bind P-selectin 
(Fig.  8). 
Based  on  studies  in  which  an  antibody  to  L-selectin 
(DREG-56) partially inhibited neutrophil adhesion to P-selec- 
tin-transfected cells, it was suggested that L-selectin is an 
important glycoprotein ligand on myeloid cells for P-selectin 
(Picker et al.,' 1991b). Although L-selectin is present in mem- 
brane extracts and WGA eluates of neutrophil membranes, 
as detected by Western blotting (Fig. 7), [~25I]P-selectin did 
not bind to L-selectin in the blotting assay.  In addition, the 
anti-L-selectin mAb DREG-56 (100/~g/ml) had no effect on 
the binding of purified P-selectin to quiescent neutrophils as 
assessed by flow cytometry (Fig. 9 a). Parallel control assays 
showed that the neutrophils expressed high levels of L-selectin 
detectable by DREG-56 (Fig. 9 b). Identical results were ob- 
tained with the anti-L-selectin mAbs DREG-55 and DREG- 
200 (data not shown). Thus, interactions with L-selectin do 
not appear to contribute to the binding of fluid-phase P-selec- 
tin to intact neutrophils or to  immobilized proteins from 
neutrophil membrane extracts. 
Discussion 
We  have  used  two  independent  and  complementary  ap- 
proaches to identify ligands for P-selectin on myeloid cells, 
blotting of neutrophil and HL-60 cell membranes and affin- 
ity chromatography of metabolically labeled HL-60 cell ex- 
tracts. The major ligand identified by both methods has an 
=250,000 and =120,000 Mr under nonreducing and reduc- 
ing conditions, respectively. The requirements for interaction 
of P-selectin with this ligand are identical to those required 
for interaction of P-selectin with intact cells (Hamburger and 
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tin blotting of neutrophil membrane pro- 
teins. Membrane extracts (200 #g protein/ 
lane) were electrophoresed on 7.5 % SDS- 
potyacrylamide gels under nonreducing or 
reducing conditions, transferred to Immo- 
bilon membranes, and probed with [12~I]P- 
selectin or murine monoclonal antibodies 
directed against human lamp-1 (CR3), hu- 
man  lamp-2  (BB6),  human  L-selectin 
(DREG-200), or human leukosialin  (Leu22). 
McEver, 1990; Geng et al., 1990; Moore et al., 1991; Corral 
et al.,  1990;  Zhou et al.,  1991).  Binding of P-selectin is 
Ca  2+ dependent, is blocked by mAbs to P-selectin that in- 
hibit the interaction between P-selectin and myeloid cells, 
and  requires  the  presence of sialic  acid  residues  on  the 
ligand. 
Sialidase  treatment  of both  ligand-enriched  neutrophil 
membrane  proteins  and  metabolically  labeled,  affinity- 
isolated ligand from HL-60 cells results in a similar increase 
in apparent molecular weight, suggesting that the ligand is 
a heavily sialylated glycoprotein. Initial loss of sialic acids 
without loss of P-selectin binding could mean that the num- 
ber of sialic acids may need to be reduced below a threshold 
level before loss of P-selectin binding is detectable in the 
blotting assay.  Alternatively, sialic acid residues critical for 
P-selectin recognition may be relatively inaccessible to siali- 
dase because of steric hindrance to enzyme action or because 
of substitutions that render them relatively resistant to diges- 
tion (Varki and Diaz,  1983). 
Because the ligand is likely to be heavily sialylated, it may 
contain numerous N-and/or O-linked oligosaccharide chains 
terminated by sialic acid. PNGaseF digestion of  both ligand- 
enriched neutrophil membrane proteins and metabolically 
labeled, afffinity-isolated  tigand from HL-60 cells causes a 
minor decrease in the apparent molecular mass of the ligand, 
but does not affect P-selectin binding. This demonstrates that 
the 120-kD ligand contains at least one N-linked chain that 
is not required for interaction with P-selectin. The glycans 
recognized by P-selectin may not be removed by PNGaseF 
because they reside on O-linked oligosaccharides. Alterna- 
tively, they might be N-linked structures that are resistant to 
cleavage by PNGaseE 
The differential mobility of the major ligand during SDS- 
PAGE in the presence and absence of reducing agents sug- 
gests that the native ligand is a disulfide-linked homodimer 
or that  a  120-kD  subunit  is  disulfide linked to a  distinct 
subunit that is not directly involved in P-selectin binding. 
Since only a 120-kD band was detected after electrophoresis 
of reduced P-selectin eluate from metabolically labeled HL- 
60 cells, a heterodimer would have to consist of nonidentical 
subunits with the same apparent molecular weight and which 
undergo the same change in electrophoretic mobility after 
sialidase  and  PNGaseF digestion.  Alternatively, the  120- 
kD-labeled subunit would have to be disulfide-linked to a 
subunit of similar apparent molecular weight that is not la- 
beled with  [3H]glucosamine.  A  homodimeric ligand  with 
Moore et al. P-Selectin  Ligand  453 Figure 8.  Western blotting and P-selectin blotting of leukosialin 
(CD43). Neutrophil WGA eluate (50/zg) and leukosialin purified 
from HL-60 cells (0.5 /zg) were electrophoresed under reducing 
conditions on 7.5% SDS-polyacrylamide gels, transferred to Im- 
mobilon,  and probed with  [~25I]P-selectin. The same membrane 
was then probed with the monoclonal anti-human leukosialin anti- 
body Leu22. 
two equivalent binding sites might enhance the avidity of the 
interaction with P-selectin. The ability of [~25I]P-selectin to 
bind to the ligand after reduction and denaturation with SDS 
suggests that higher order structural features of the protein 
are 'not critical for recognition. 
The blotting assay also detected two minor ligands.  The 
first has  an  =250,000  Mr  under  reducing  conditions.  Be- 
cause its mobility is identical to that of the major ligand un- 
der nonreducing conditions, it may represent a  subpopula- 
tion of the major ligand that is resistant to reduction. The 
second has an ---160,000 Mr under nonreducing conditions. 
Binding of P-selectin to both minor ligands  was  Ca  2§ de- 
pendent and blocked by the mAb G1. 
The isolation of a single glycoprotein from metabolically 
labeled HL-60 cells suggests that P-selectin has a  marked 
preference for a particular ligand structure. It is noteworthy 
that L-selectin, which is expressed on leukocytes and binds 
to  sialylated  structures  on  endothelial  cells  (True et  al., 
1990), interacts preferentially with 50- and 90-kD sulfated, 
fucosylated glycoproteins from  murine  peripheral  lymph 
nodes (Imai et al., 1991). Thus, both P-selectin and L-selec- 
tin appear to interact with a  small  subset of glycoprotein 
ligands. 
It has been demonstrated that L-selectin on neutrophils 
carries the sialyl Lex epitope and that a mAb to L-selectin 
partially blocks neutrophil adhesion to cells transfected with 
P-selectin cDNA (Picker et al.,  1991b).  Based on these ob- 
servations, it was proposed that L-selectin on neutrophils is 
a predominant ligand for P-selectin. However, no direct in- 
teraction  of L-selectin with  P-selectin  was  demonstrated 
(Picker et al., 1991b). In the present study we have been un- 
able to detect binding of  P-selectin to L-selectin in neutrophil 
membrane extracts. Furthermore, the binding of P-selectin 
to intact neutrophils is unaltered by antibodies to L-selectin 
(this study) or by neutrophil activation that causes shedding 
of L-selectin from the cell surface (Moore et al.,  1991). Al- 
though it is conceivable that L-selectin has weak affinity for 
P-selectin, the significance of this potential interaction re- 
mains to be established. 
A recombinant P-selectin IgG chimera was shown to bind 
to myeloid cells and to sulfatide,  Gal(3-SO4)/31-Ceramide 
(Aruffo et  al.,  1991).  Sulfatide also  inhibited  interaction 
of the chimera with monocytoid U937 cells (Aruffo et al., 
1991). It was not demonstrated whether binding of the P-selec- 
tin chimera to the cells or to sulfatide was Ca  2+ dependent, 
a  fundamental characteristic of selectin-dependent cellular 
interactions  (McEver,  1991).  Protease digestion  of intact 
ceils should increase the accessibility of P-selectin to poten- 
tial glycolipid ligands such as sulfatides (Watanabe and Hako- 
mori, 1976; Stein et al., 1978). However, protease treatment 
abolishes binding of P-selectin to neutrophils (Moore et al., 
1991)  and  HL-60 cells (Zhou et al.,  1991;  Aruffo et al., 
1992)  as  well  as  adhesion of neutrophils  to  immobilized 
P-selectin (K.L. Moore and R.P. McEver, unpublished ob- 
servations). In addition, although erythrocytes and platelets 
express  sulfatides  (Roberts  et  al.,  1985;  Hansson  et  al., 
1978), they do not specifically interact with P-selectin (Moore 
et al., 1991; Larsen et al., 1989). Thus, it seems unlikely that 
sulfatides are the principal mediators of adhesion of myeloid 
cells to P-selectin. It remains to be determined whether sul- 
fatides inhibit binding of P-selectin to myeloid cells by spe- 
cific competition with a  glycoprotein ligand or by indirect 
effects.  It is possible that the P-selectin ligand we have de- 
scribed is sulfated or contains other structural features that 
are mimicked by sulfatides. 
Previous studies have shown that P-selectin interacts with 
o~(2-3) sialylated, offl-3)fucosylated lactosaminoglycans, of 
which  one is  the  sialyl  Le  x tetrasaccharide  (Zhou et al., 
1991;  Polley et al.,  1991).  However, several observations 
suggest that the sialyl Le  x tetrasaccharide per se does not 
bind with high affinity to P-selectin. First,  some (Policy et 
al.,  1991)  but  not  all  investigators  (Moore  et  al.,  1991; 
Aruffo et al.,  1991) have found that sialyl Le  x inhibits inter- 
actions of myeloid cells with P-selectin. Second, CHO ceils 
transfected with a  fucosyltransferase express sialyl Le  x yet 
bind P-selectin with significantly lower affinity than do my- 
eloid cells (Zhou et al.,  1991).  Third, HT-29 ceils, which 
also express sialyl Le  x, do not interact at all with P-selectin 
(Zhou et al.,  1991).  Finally, several neutrophil membrane 
proteins known to carry the sialyl Le  x structure (Lee et al., 
1990; Picker et al., 1991b; Asada et al., 1991; Fukuda et al., 
1984), are distinct from the major glycoprotein ligand we 
have identified and do not bind P-selectin in the assays de- 
scribed here. These observations suggest that the ligand we 
have identified contains structural features in addition to the 
sialyl Le  x tetrasaccharide that enhance the affinity and/or 
specificity of its interaction with P-selectin. 
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Figure 9. Effect of anti-L-selec- 
tin mAbs on P-selectin binding 
to human neutrophils. (A) Neu- 
trophils were preincubated for 
15 min with buffer alone (1 and 
2),  100  #g/ml  of the  anti-L- 
selectin  monoclonal  antibody 
(mAb)  DREG-56  (3),  or  100 
/~g/ml  of  the  anti-P-selectin 
mAb G1  (4) before addition of 
buffer (1)  or P-selectin (2-4). 
P-selectin binding was then de- 
tected by sequential incubation 
of the  ceils  with  biotinylated 
S12 (a noninhibitory monoclo- 
hal antibody to P-selectin) and 
phycoerythrin-strept  avidin  as 
described  in  Materials  and 
Methods, Histograms 1 and 4 
and  histograms 2  and  3  were 
superimposable but were offset 
slightly for the purpose of clar- 
ity.  (B) In parallel experiments 
binding  of  the  anti-L-selectin 
mAb DREG-56 to the neutro- 
phils was assessed by  indirect 
immunofluorescence  using  a 
phycoerythrin-conjugated  anti- 
murine  IgG~  antibody  (PE- 
~lgG/). 
The  methods  used  in  this  study  to  identify  P-selectin 
ligands have certain limitations. The blotting procedure will 
not detect ligands whose function is destroyed by denatura- 
tion with SDS, nor will studies using metabolically-labeled 
HL-60 cells detect ligands which do not label with [3H]glu- 
cosamine.  Therefore we cannot exclude the possibility that 
other relevant P-selectin ligands exist. Nevertheless, affinity 
chromatography has the major advantage that it should iden- 
tify the ligand(s) with relatively high affinity for P-selectin, 
which are likely to be physiologically relevant. Further stud- 
ies are required to determine whether the ligand character- 
ized here accounts for the limited number of binding sites for 
[]25I]P-selectin  on  intact  neutrophils  (Moore et  al.,  1991) 
and plays a role in adhesion of myeloid cells to P-selectin ex- 
pressed on activated platelets and endothelial cells. 
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